Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-06873600 |
Trade Name | |
Synonyms | PF 06873600|PF06873600 |
Drug Descriptions |
PF-06873600 selectively inhibits CDK 2/4/6, potentially leading to antitumor activity (Cancer Res (2022) 82 (4_Supplement): P5-16-06). |
DrugClasses | CDK2 Inhibitor 31 CDK4 Inhibitor 17 CDK6 Inhibitor 6 |
CAS Registry Number | 2185857-97-8 |
NCIT ID | C151988 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fulvestrant + PF-06873600 | Fulvestrant PF-06873600 | 0 | 0 |
PF-06873600 | PF-06873600 | 0 | 1 |
PF-06873600 + SCH772984 | PF-06873600 SCH772984 | 0 | 0 |